Access Digital Health
CountriesInterventionsToolsAbout
Log in
← Interventions

Pentavalent vaccine (DPT + Hep B + Hib)

Cost-effectiveness — what published models estimate per unit of health impact
$/DALY
$29–100
WHO-CHOICE modeled
GiveWell
1.2×
cash multiple
CE sources
3
Tier A · 35 studies
Source agreement
material
sources differ
Scope to country:All countries
Loading effectiveness evidence…
Cost-effectiveness

Estimates are sourced in their native units and shown for comparison, not as literal costs. Sources use different frameworks — see each card for what it represents and how it was derived.

Modeled benchmarks ($/DALY)Tier A · standardized benchmark
Eastern sub-Saharan Africa$29.23View source →
South-East Asia$100.39View source →

WHO-CHOICE estimates are modeled at 50% population coverage, compared against the null set (no intervention) under generalized cost-effectiveness analysis. View WHO-CHOICE methodology →

$/DALY sources differ by 3.4x - a material difference.

Modeled regional estimates — not realized delivery costs.

GiveWell program model (× cash)Tier A · program model
New Incentives · New Incentives 2024
Geography× cashlives / M$ / lifegrant
Sokoto, Nigeria38.6736$1,359$1.0M
Zamfara, Nigeria31.3585$1,711$1.0M
Kebbi, Nigeria29.0558$1,792$1.0M

GiveWell’s published mortality & grant figures per geography. Click any × cash value for full provenance and GiveWell’s own DALY-approx.

Focus a geography

Different framework — not comparable to the $/DALY axis. Native unit is multiples of cash transfers.

Published study estimates ($/DALY)Tier B · context only

Tufts GHCEA · 35 studies, varied methods — explore the spread, not a single number.

Health-system
$3,068
median · n=29
Mixed
$51
median · n=4
Societal
$942
median · n=2
Filter the cohort
$1,181median of 35 studies · IQR $2–$85,344 · 6 cost-saving
Data completeness: not assessed (no country selected) · Evidence confidence: not assessed (no country selected)
Delivery readiness is not currently shown. The country health-system view — workforce density, financing mix, service coverage — is being rebuilt as part of the scenario layer. The underlying indicators remain in the country pages.
The figures above are published benchmarks. To build an investment case for your own context — local unit costs, target population, coverage assumptions — model it directly. Select a country first to carry its context into the model.
Choose a country to model →
Looking for supply/market data for Pentavalent vaccine (DPT + Hep B + Hib)? Select a country above, then open its intelligence page.